Dr. Narain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
865 Northern Blvd
Suite 302
Great Neck, NY 11021Phone+1 516-708-2550
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2012 - 2014
MetroWest Medical CenterResidency, Internal Medicine, 2009 - 2012
Adichunchanagiri Institute of Medical SciencesClass of 1999
Certifications & Licensure
NY State Medical License 2014 - 2026
MA State Medical License 2009 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Clinical Trials
- Study of Anti-Malarials in Incomplete Lupus Erythematosus Start of enrollment: 2017 Dec 28
Roles: Contact
- Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 5 citationsBelimumab treatment of adult idiopathic inflammatory myopathy.Galina Marder, Tam Quach, Priyal Chadha, Preeya Nandkumar, Jimmy Tsang
Rheumatology. 2024-03-01 - 54 citationsComparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.Sonali Narain, Dimitre G. Stefanov, Alice S. Chau, Andrew G. Weber, Galina Marder
Chest. 2021-03-01 - 74 citationsIncreased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupusYi Li, Pui Y. Lee, Eric S. Sobel, Sonali Narain, Minoru Satoh
Arthritis Research & Therapy. 2009-01-14
Press Mentions
- Clinical Trials and Research News Weekly Roundup | Treat COVID-19 Patients Early Antiviral Cocktail?November 2nd, 2020
- Feinstein Institutes for Medical Research Breakthrough on How to Treat COVID-19 Cytokine StormOctober 22nd, 2020
- Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm'October 16th, 2020
Professional Memberships
- Fellows-in-Training 3rd year
Other Languages
- Hindi, Kannada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
